Developer docs
API playgroundTry for free, no card

Search company profiles

SanaClis

Full company profile

uuid000bmp9

Namestring
SanaClis
Legal namestring
SanaClis s.r.o.
Websiteurl
sanaclis.eu
Company typeenum
Private
Founded yearint
2000
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBratislava
HQ citystring
Bratislava
Markets served

Serves global market

Keyword5 values
contract research organization, clinical trial services, clinical supply chain, pharmaceutical research services, biotech clinical operations
Industry5 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1CRO Services
TypeProfessional Services
Description

Full-service Contract Research Organization services including clinical monitoring, project management, regulatory services, medical writing, pharmacovigilance, medical monitoring, data management, biostatistics, site management, and decentralized trials. Revenue is generated through service contracts with pharmaceutical, biotechnology, and medical device companies for clinical trial management.

sanaclis.com
2Clinical Supply Chain Services
TypeManaged Services
Description

Integrated clinical supply chain services including global strategic sourcing, supply chain quotation, qualified person services, storage and distribution, secondary packaging and labelling, customs clearance and brokerage, and direct-to-patient services. Revenue derived from logistics and supply chain management fees.

sanaclis.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SanaClis is a global full-service Contract Research Organization (CRO) that delivers end-to-end clinical trial services combined with integrated clinical supply chain management for pharmaceutical, biotechnology, and medical device sponsors. The company operates GMP- and GDP-certified clinical trial storage and distribution depots worldwide, manages investigational medicinal product logistics, and provides clinical operations, regulatory, pharmacovigilance, data management, and biostatistics support under both full-service and Functional Service Provider (FSP) collaboration models.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 93% of studies finished ahead of schedule and budget
+2 more records
Product overview1 text field

SanaClis is a global full-service Contract Research Organization (CRO) founded in 2000, offering a unified platform of integrated clinical research and supply chain services. The company's portfolio comprises two core product lines: CRO Services (encompassing quality management, project management, clinical monitoring, regulatory services, medical writing, pharmacovigilance, medical monitoring, data management, biostatistics, site management, and decentralized trials) and Clinical Supply Chain Services (including global strategic sourcing, SIMS management system, supply chain quotation, qualified person services, storage and distribution, secondary packaging and labelling, customs clearance, and direct-to-patient services). The company operates both as a traditional full-service CRO and under a Functional Service Provider (FSP) model, serving pharmaceutical, biotechnology, and medical device companies across specialized sectors including cell and gene therapies, medical devices, biosimilars, and general biotech/pharma. SanaClis maintains an integrated approach where the CRO Services and Clinical Supply Chain Services work together end-to-end across all phases of clinical development.

Product and service4 records
1CRO Services
CategoryClinical Research Services
Description

Full-service Contract Research Organization offerings covering the entire clinical trial lifecycle including quality management, project management, clinical monitoring, regulatory services, medical writing, pharmacovigilance, medical monitoring, data management, biostatistics, site management, and decentralized trials, delivered to pharmaceutical, biotechnology, and medical device sponsors.

2Clinical Supply Chain Services
CategoryClinical Logistics Services
Description

Integrated clinical supply chain solutions including global strategic sourcing, supply chain quotation, qualified person services, storage and distribution, secondary packaging and labelling, customs clearance and brokerage, and direct-to-patient services for investigational medicinal products.

3Functional Service Provider (FSP) Model
CategoryService Engagement Model
Description

Flexible collaboration model that allows sponsors to scale resources and tailor support according to the specific needs of each clinical program, operating alongside the full-service CRO offering.

4SIMS (SanaClis Interactive Management System)
CategoryClinical Trial Management Software
Description

Proprietary online access platform for clinical supply chain management, providing clients with portal-based interactive tools to manage trial logistics, inventory, and supply chain operations.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mid-to-large full-service CRO with deep scientific/therapeutic-area expertise and an owner-operator model closely analogous to SanaClis' positioning, serving similar biotech through mid-pharma sponsors.

TypeDirect peer
Description

Privately held global full-service CRO covering the same clinical operations, regulatory, biostatistics, and pharmacovigilance service lines as SanaClis, competing for the same enterprise pharma programs.

TypeDirect peer
Description

Pure-play clinical CRO spun out of LabCorp, offering full-service clinical operations alongside central lab testing — directly competitive on the same CRO-services RFPs and adjacent to SanaClis' supply chain offering.

TypeBroad incumbent
Description

The largest global full-service CRO and clinical technology provider. Comparable because it offers end-to-end clinical trial services plus adjacent data/technology capabilities that SanaClis also targets, albeit at vastly greater scale.

TypeDirect peer
Description

Top-tier global full-service CRO with comparable breadth across clinical operations, biostatistics, regulatory, and laboratory services. Direct competitor for the same pharma and biotech sponsor RFPs that SanaClis targets.

TypeDirect peer
Description

Global full-service CRO with clinical and commercial capabilities, competing head-to-head for biotech and pharma study awards across all phases.

TypeDirect peer
Description

Mid-sized, PE-backed full-service CRO with comparable therapeutic-area expertise and pharma/biotech client mix — the closest size-and-model analogue to SanaClis in the market.

TypeBroad incumbent
Description

Global central and specialty laboratory provider for clinical trials. Adjacent to SanaClis' supply chain and trial services where laboratory testing intersects with clinical operations, though Eurofins does not provide the broader CRO suite.

TypeBroad incumbent
Description

Diversified CRO with preclinical discovery plus clinical and manufacturing services. Comparable as an established incumbent capturing outsourced R&D spend, though SanaClis does not compete in its preclinical franchise.

TypeEmerging player
Description

Leading China-based full-service CRO with growing international presence, increasingly competing in Europe on biotech trials — a relevant emerging peer for SanaClis' global sponsor pitches.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SanaClis

Contract Research Organization Servicessanaclis.eu

SanaClis firmographics

Firmographics
Name
SanaClis
Legal name
SanaClis s.r.o.
Website
https://sanaclis.eu
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

SanaClis industry classification

Industry
Product category
Contract Research Organization Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs

Keywords

  • Contract research organization
  • Clinical trial services
  • Clinical supply chain
  • Pharmaceutical research services
  • Biotech clinical operations

Where SanaClis is headquartered

Location

Headquarters

HQ city
Bratislava

Markets served

SanaClis business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. CRO Services: Full-service Contract Research Organization services including clinical monitoring, project management, regulatory services, medical writing, pharmacovigilance, medical monitoring, data management, biostatistics, site management, and decentralized trials. Revenue is generated through service contracts with pharmaceutical, biotechnology, and medical device companies for clinical trial management.
  2. Clinical Supply Chain Services: Integrated clinical supply chain services including global strategic sourcing, supply chain quotation, qualified person services, storage and distribution, secondary packaging and labelling, customs clearance and brokerage, and direct-to-patient services. Revenue derived from logistics and supply chain management fees.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

SanaClis product offering

Product offering

Core offering

SanaClis is a global full-service Contract Research Organization (CRO) that delivers end-to-end clinical trial services combined with integrated clinical supply chain management for pharmaceutical, biotechnology, and medical device sponsors. The company operates GMP- and GDP-certified clinical trial storage and distribution depots worldwide, manages investigational medicinal product logistics, and provides clinical operations, regulatory, pharmacovigilance, data management, and biostatistics support under both full-service and Functional Service Provider (FSP) collaboration models.

Product overview

SanaClis is a global full-service Contract Research Organization (CRO) founded in 2000, offering a unified platform of integrated clinical research and supply chain services. The company's portfolio comprises two core product lines: CRO Services (encompassing quality management, project management, clinical monitoring, regulatory services, medical writing, pharmacovigilance, medical monitoring, data management, biostatistics, site management, and decentralized trials) and Clinical Supply Chain Services (including global strategic sourcing, SIMS management system, supply chain quotation, qualified person services, storage and distribution, secondary packaging and labelling, customs clearance, and direct-to-patient services). The company operates both as a traditional full-service CRO and under a Functional Service Provider (FSP) model, serving pharmaceutical, biotechnology, and medical device companies across specialized sectors including cell and gene therapies, medical devices, biosimilars, and general biotech/pharma. SanaClis maintains an integrated approach where the CRO Services and Clinical Supply Chain Services work together end-to-end across all phases of clinical development.

Differentiator

Problem solved

Functional benefit

Products and services

  • CRO Services Full-service Contract Research Organization offerings covering the entire clinical trial lifecycle including quality management, project management, clinical monitoring, regulatory services, medical writing, pharmacovigilance, medical monitoring, data management, biostatistics, site management, and decentralized trials, delivered to pharmaceutical, biotechnology, and medical device sponsors.
  • Clinical Supply Chain Services Integrated clinical supply chain solutions including global strategic sourcing, supply chain quotation, qualified person services, storage and distribution, secondary packaging and labelling, customs clearance and brokerage, and direct-to-patient services for investigational medicinal products.
  • Functional Service Provider (FSP) Model Flexible collaboration model that allows sponsors to scale resources and tailor support according to the specific needs of each clinical program, operating alongside the full-service CRO offering.
  • SIMS (SanaClis Interactive Management System) Proprietary online access platform for clinical supply chain management, providing clients with portal-based interactive tools to manage trial logistics, inventory, and supply chain operations.

Quantifiable outcome

  • 93% of studies finished ahead of schedule and budget
  • +2 more outcomes

Companies that use SanaClis

Customer profile

Segments4 records

Ideal customer profiles4 records

SanaClis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

SanaClis partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

SanaClis competitors and assessment

Company assessment

Direct peers

  • Medpace: Mid-to-large full-service CRO with deep scientific/therapeutic-area expertise and an owner-operator model closely analogous to SanaClis' positioning, serving similar biotech through mid-pharma sponsors.
  • Parexel International: Privately held global full-service CRO covering the same clinical operations, regulatory, biostatistics, and pharmacovigilance service lines as SanaClis, competing for the same enterprise pharma programs.
  • Fortrea (former LabCorp/Covance Clinical Development): Pure-play clinical CRO spun out of LabCorp, offering full-service clinical operations alongside central lab testing — directly competitive on the same CRO-services RFPs and adjacent to SanaClis' supply chain offering.
  • ICON plc: Top-tier global full-service CRO with comparable breadth across clinical operations, biostatistics, regulatory, and laboratory services. Direct competitor for the same pharma and biotech sponsor RFPs that SanaClis targets.
  • Syneos Health: Global full-service CRO with clinical and commercial capabilities, competing head-to-head for biotech and pharma study awards across all phases.
  • Worldwide Clinical Trials: Mid-sized, PE-backed full-service CRO with comparable therapeutic-area expertise and pharma/biotech client mix — the closest size-and-model analogue to SanaClis in the market.

Broad incumbents

  • IQVIA: The largest global full-service CRO and clinical technology provider. Comparable because it offers end-to-end clinical trial services plus adjacent data/technology capabilities that SanaClis also targets, albeit at vastly greater scale.
  • Eurofins Central Laboratory: Global central and specialty laboratory provider for clinical trials. Adjacent to SanaClis' supply chain and trial services where laboratory testing intersects with clinical operations, though Eurofins does not provide the broader CRO suite.
  • Charles River Laboratories: Diversified CRO with preclinical discovery plus clinical and manufacturing services. Comparable as an established incumbent capturing outsourced R&D spend, though SanaClis does not compete in its preclinical franchise.

Emerging players

  • Tigermed: Leading China-based full-service CRO with growing international presence, increasingly competing in Europe on biotech trials — a relevant emerging peer for SanaClis' global sponsor pitches.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

SanaClis social profiles

Digital presence

SanaClis compliance and trust

Trust signal

Compliance2 records

SanaClis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SanaClis leadership team

Management profile

Number of profiles

Profiles1 record

SanaClis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SanaClis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SanaClis

What does SanaClis do?

SanaClis is a global full-service Contract Research Organization (CRO) that delivers end-to-end clinical trial services combined with integrated clinical supply chain management for pharmaceutical, biotechnology, and medical device sponsors. The company operates GMP- and GDP-certified clinical trial storage and distribution depots worldwide, manages investigational medicinal product logistics, and provides clinical operations, regulatory, pharmacovigilance, data management, and biostatistics support under both full-service and Functional Service Provider (FSP) collaboration models.

Is SanaClis a public or private company?

SanaClis is a private company. It is classified as unknown and is currently operating.

When was SanaClis founded?

SanaClis was founded in 2000. It employs 101 to 250 people.

Where is SanaClis based?

SanaClis is headquartered in Bratislava.

How does SanaClis make money?

Two revenue lines are on record. CRO Services are the primary driver. The others are clinical Supply Chain Services.

Who are SanaClis's main competitors?

Direct peers on record are Medpace, Parexel International, Fortrea (former LabCorp/Covance Clinical Development), ICON plc, Syneos Health and Worldwide Clinical Trials. Broad incumbents are IQVIA, Eurofins Central Laboratory and Charles River Laboratories. Tigermed is listed as an emerging player.

Does SanaClis have an API?

No public API is recorded for SanaClis.

What industry is SanaClis in?

SanaClis's product category is Contract Research Organization Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs. Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals